Ex parte CORTRIGHT - Page 7




          Appeal No. 94-4260                                                          
          Application 07/849,191                                                      


          claim 15; nor does it provide any guidance as to how to assay               
          for the claimed results.  That is, the specification does not               
          provide any assays by which one skilled in the art could                    
          determine whether the effects of lower male hormone levels                  
          have been offset, or even if BAG BALM  has reached theŽ                                      
          papilla.  Accordingly, we maintain our position that with                   
          respect to claim 15, the appellant is “tossing out the mere                 
          germ of an idea.”  Genentech Inc. V. Novo Nordisk A/S, 108                  
          F.3d 1361, 1366, 42 USPQ2d 1001, 1005 (Fed. Cir. 1997).  The                
          specification “provides only a starting point, a direction for              
          further research.”  Id.                                                     


               No time period for taking any subsequent action in                     
          connection with this appeal may be extended under 37 CFR §                  
          1.136(a).                                                                   
                                       DENIED                                         









                                          7                                           





Page:  Previous  1  2  3  4  5  6  7  8  Next 

Last modified: November 3, 2007